Inhibitor Therapeutics, Inc. Loss Contingency Accrual, Product Liability, Next Rolling Twelve Months
Inhibitor Therapeutics, Inc. (INTI) had Loss Contingency Accrual, Product Liability, Next Rolling Twelve Months of $15.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency Accrual, Product Liability, Gross, Rolling Maturity
us-gaap:LossContingencyAccrualProductLiabilityDueInNextRollingTwelveMonths · last filed 2026-03-26
- 2025-12-31: Loss Contingency Accrual, Product Liability, Next Rolling Twelve Months $15.00K.
| Period end | Loss Contingency Accrual, Product Liability, Next Rolling Twelve Months |
|---|---|
| 2025-12-31 | $15.00K 10-K · filed 2026-03-26 |